Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease

被引:67
|
作者
Du, Xi-Xun [1 ]
Xu, Hua-Min [1 ]
Jiang, Hong [1 ]
Song, Ning [1 ]
Wang, Jun [1 ]
Xie, Jun-Xia [1 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
6-hydroxydopamine; curcumin; Parkinson's disease; dopaminergic neurons; iron; METAL TRANSPORTER 1; SUBSTANTIA-NIGRA; ANIMAL-MODELS; ANTIOXIDANT; CELLS; DEGENERATION; FLAVONOIDS; CADMIUM; BRAIN; MPTP;
D O I
10.1007/s12264-012-1238-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDAlesioned rat model of Parkinson's disease in vivo. Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. The dopamine content in the striatum and the number of TH-immunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. The protective effects of curcumin against 6-OHDA may be attributable to the ironchelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [21] Neurorescue Effect of Rosmarinic Acid on 6-Hydroxydopamine-Lesioned Nigral Dopamine Neurons in Rat Model of Parkinson's Disease
    Jieyu Wang
    Huamin Xu
    Hong Jiang
    Xixun Du
    Peng Sun
    Junxia Xie
    Journal of Molecular Neuroscience, 2012, 47 : 113 - 119
  • [22] Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease
    Fletcher, Edward J. R.
    Moon, Lawrence D. F.
    Duty, Susan
    BMC NEUROSCIENCE, 2019, 20 (01)
  • [23] JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
    Crocker, Candice E.
    Khan, Susan
    Cameron, Michael D.
    Robertson, Harold A.
    Robertson, George S.
    LoGrasso, Philip
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (04): : 207 - 212
  • [24] Neonatal 6-hydroxydopamine lesioning of rats and dopaminergic neurotoxicity: proposed animal model of Parkinson's disease
    Kostrzewa, Richard M.
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (5-6) : 445 - 461
  • [25] Impaired Voluntary Wheel Running Behavior in the Unilateral 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Pan, Qi
    Zhang, Wangming
    Wang, Jinyan
    Luo, Fei
    Chang, Jingyu
    Xu, Ruxiang
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2015, 57 (02) : 82 - 87
  • [26] 6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat
    Hong-Il Yoo
    Gil-Yeong Ahn
    Eun-Jin Lee
    Eu-gene Kim
    Sung-Young Hong
    Sang-Jin Park
    Ran-Sook Woo
    Tai-Kyoung Baik
    Dae-Yong Song
    Molecular & Cellular Toxicology, 2017, 13 : 305 - 315
  • [27] 6-Hydroxydopamine induces nuclear translocation of apoptosis inducing factor in nigral dopaminergic neurons in rat
    Yoo, Hong-Il
    Ahn, Gil-Yeong
    Lee, Eun-Jin
    Kim, Eu-gene
    Hong, Sung-Young
    Park, Sang-Jin
    Woo, Ran-Sook
    Baik, Tai-Kyoung
    Song, Dae-Yong
    MOLECULAR & CELLULAR TOXICOLOGY, 2017, 13 (03) : 305 - 315
  • [28] Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion
    Zuch, CL
    Nordstroem, VK
    Briedrick, LA
    Hoernig, GR
    Granholm, AC
    Bickford, PC
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 427 (03) : 440 - 454
  • [29] Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
    Marinova-Mutafchieva, Lilia
    Sadeghian, Mona
    Broom, Lauren
    Davis, John B.
    Medhurst, Andrew D.
    Dexter, David T.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 (03) : 966 - 975
  • [30] The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study
    Liu, Cheng-Tsung
    Kao, Li-Ting
    Shih, Jui-Hu
    Chien, Wu-Chien
    Chiu, Chuang-Hsin
    Ma, Kuo-Hsing
    Huang, Yuahn-Sieh
    Cheng, Cheng-Yi
    Shiue, Chyng-Yann
    Li, I-Hsu
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 862